Results 1 to 10 of about 10,270 (162)

Factor de Impacto (JCR)

open access: yesBotan‪ical Sciences, 2022
Elementos Blog Botanical ...
Dalila Fragoso Tejas
doaj   +3 more sources

Information Resources: Differential Characteristics between Ibero-American and Dutch JCR Psychology Journals from 1998 to 2017

open access: yesResources, 2019
The objective of this study is to compare the evolution of the Psychology journals included in the Journal Citation Report (JCR) databases (Science Citation Index (SCI) and Social Sciences Citation Index (SSCI)) in the last 20 years (from 1998 to 2017 ...
Julia Osca-Lluch   +2 more
exaly   +3 more sources

An Efficient Spectral Approach for JCR Narrow Band Signals in Presence of Multipath and Noise

open access: yesIEEE Open Journal of the Communications Society
Joint Communication Radar (JCR) systems have garnered significant attention due to their ability to simultaneously perform communication and radar sensing tasks.
Massinissa Belazzoug   +2 more
exaly   +3 more sources

Moving forward to JCR [PDF]

open access: yesFarmacia Hospitalaria, 2017
Teresa Bermejo Vicedo
doaj   +3 more sources

Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis

open access: yesPharmaceutics, 2022
Enzyme replacement therapy (ERT) has paved the way for treating the somatic symptoms of lysosomal storage diseases (LSDs), but the inability of intravenously administered enzymes to cross the blood–brain barrier (BBB) has left the central nervous system (
Hiroyuki Sonoda   +8 more
doaj   +1 more source

Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme

open access: yesMolecular Genetics and Metabolism Reports, 2022
Neuronal ceroid lipofuscinosis type 1(CLN1 disease) is a rare autosomal recessive lysosomal storage disease caused by genetic defects of palmitoyl protein thioesterase-1(PPT1), leading to accumulation of lipofuscin granules in brain and progressive ...
Andreas Hahn   +7 more
doaj   +1 more source

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice

open access: yesMolecular Therapy: Methods & Clinical Development, 2023
Mucopolysaccharidosis I (MPS I), a lysosomal storage disease caused by dysfunction of α-L-iduronidase (IDUA), is characterized by the deposition of dermatan sulfate (DS) and heparan sulfate (HS) throughout the body, which causes several somatic and ...
Sachiho Kida   +15 more
doaj   +1 more source

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II

open access: yesMolecular Genetics and Metabolism Reports, 2021
Pabinafusp alfa is a fusion protein comprising a humanized anti-human transferrin receptor (TfR) antibody and human iduronate-2-sulfatase. It was developed as a novel modality to target central nervous system-related symptoms observed in patients with ...
Ryuji Yamamoto   +6 more
doaj   +1 more source

Influence of open access journals on the research community in Journal Citation Reports [PDF]

open access: yesScience Editing, 2021
Purpose The number of open access (OA) journals is rapidly increasing, and it is very important for librarians to understand the influence of OA journals on the research community.
Sang-Jun Kim, Kay Sook Park
doaj   +1 more source

Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice

open access: yesMolecular Therapy: Methods & Clinical Development, 2022
Deposition of heparan sulfate (HS) in the brain of patients with mucopolysaccharidosis II (MPS II) is believed to be the leading cause of neurodegeneration, resulting in several neurological signs and symptoms, including neurocognitive impairment.
Hideto Morimoto   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy